| Names | |
|---|---|
| Preferred IUPAC name | Cyclopropanecarboxamide |
| Other names | Cyclopropanecarboxylic acid amide Cyclopropanecarbonamide |
| Pronunciation | /ˌsaɪ.kloʊˌproʊ.peɪn.kɑːrˈbɒk.sə.maɪd/ |
| Identifiers | |
| CAS Number | 6224-10-2 |
| Beilstein Reference | 1434453 |
| ChEBI | CHEBI:77793 |
| ChEMBL | CHEMBL42133 |
| ChemSpider | 55718 |
| DrugBank | DB04494 |
| ECHA InfoCard | 03d8da5e-013e-4f6c-8953-63cf014b23a5 |
| EC Number | 210-849-4 |
| Gmelin Reference | 7661 |
| KEGG | C07311 |
| MeSH | D038491 |
| PubChem CID | 69710 |
| RTECS number | GZ9575000 |
| UNII | Z9V1J48G1M |
| UN number | UN3276 |
| CompTox Dashboard (EPA) | DTXSID10918068 |
| Properties | |
| Chemical formula | C4H7NO |
| Molar mass | 85.109 g/mol |
| Appearance | White to light yellow solid |
| Odor | Odorless |
| Density | 1.056 g/cm³ |
| Solubility in water | soluble |
| log P | -0.2 |
| Vapor pressure | 1.97E-01 mmHg at 25°C |
| Acidity (pKa) | 19.6 |
| Basicity (pKb) | 2.84 |
| Magnetic susceptibility (χ) | -38.2·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.457 |
| Dipole moment | 3.96 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 314.3 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -61.9 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -565.7 kJ/mol |
| Pharmacology | |
| ATC code | N01AX15 |
| Hazards | |
| Main hazards | Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | P261, P264, P271, P272, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P362+P364, P501 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 108°C |
| Autoignition temperature | 473°C |
| Lethal dose or concentration | LD₅₀ Oral Rat 1000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Rat oral 830 mg/kg |
| NIOSH | RN2000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 grams |
| Related compounds | |
| Related compounds | Cyclopropanecarboxylic acid Cyclopropanecarbonitrile Cyclopropylamine Cyclopropyl isocyanate Cyclopropanecarbonyl chloride |
| Item | Description |
|---|---|
| Product Name | Cyclopropanecarboxamide |
| IUPAC Name | Cyclopropanecarboxamide |
| Chemical Formula | C4H7NO |
| CAS Number | 765-77-7 |
| Synonyms & Trade Names | Cyclopropanecarboxylic acid amide; Cyclopropanecarboxamid |
| HS Code & Customs Classification | 2924.29 (Amides and their derivatives, specific to cyclopropanecarboxamide type compounds; exact customs code requires regional confirmation) |
Our direct production experience with cyclopropanecarboxamide covers both process development and scale-up for research and specialty applications. In industrial practice, the raw material selection involves assessing the purity and sourcing of cyclopropanecarboxylic acid or its esters. The primary consideration is the content and volatility of side-chain impurities, which directly influence the downstream amide formation and overall batch consistency. Hydrolysis sensitivity tends to be batch-dependent, so intermediate handling requires anhydrous and low-temperature conditions to suppress byproduct formation.
Choice of amination technique plays a role in controlling secondary amine content and potential ring-opening side-products. The optimal route often comes down to targeted end-use, with pharmaceutical and fine chemical applications driving requirements for higher, process-specific purities. Our quality control focuses on the uniformity of the cyclopropane ring signal by GC or NMR, as mismanaged process parameters can lead to degradation or oligomerization. Batch-to-batch consistency remains the highest customer concern, so release specifications are finalized in alignment with customer analytical requirements, and routines consider both in-process and final release assays.
Storage stability links to product moisture content and packaging integrity. This compound’s sensitivity to acid and base catalysis requires tight atmospheric controls during both packing and transit. For downstream formulation, particle size distribution and residual solvent levels are grade-controlled to support fit into the chosen process—whether direct chemical synthesis or formulation into end-use products. Bulk handlers in export markets may require further stabilization, depending on storage infrastructure and climate conditions.
Customs classification under the HS system commonly refers to the amides group, but definitive assignment should align with both product application and most recent regional regulatory updates. The best industrial outcomes arise from close alignment between manufacturer process control and end user specification, which dictates the analytical regime from raw material entry through to final container filling.
Industrial batches of cyclopropanecarboxamide appear as a solid, typically forming colorless to off-white crystalline material. Odor is faint and amide-like, often detectable only upon close inspection during open handling. Melting point varies by purity, with trace impurities or moisture content affecting crystallization behavior. Boiling point remains less relevant under normal conditions, as the product is usually processed and handled below decomposition temperatures. Flash point is not routinely measured in manufacturing settings but is considered during risk assessments for dust and thermal processing.
Measured density can fluctuate depending on powder compaction and solvated fraction. Bulk density informs packaging and handling protocols. Analytical density measurement is only critical for high-purity, customer-specified lots.
Cyclopropanecarboxamide remains chemically stable in tightly controlled, dry storage. Exposure to strong acids, bases, or oxidizers leads to hydrolysis or ring-opening reactions. Manufacturing employs closed systems and controlled atmospheres to restrict contaminant ingress, as minor impurities accelerate decomposition or discoloration over extended storage.
Solubility in common polar solvents depends both on grade and on the presence of surface-active impurities. Certified pharmaceutical or analytical grades demand clear, particle-free solutions; industrial material may present slight haze or undissolved particulates if secondary crystallization is incomplete. Solution preparation requires slow addition and agitation to control solution temperature and limit degradation, particularly at higher concentrations.
| Grade | Main Assay Target | Key Impurities (General) | Application Sensitivity |
|---|---|---|---|
| Technical | Typical values depending on synthesis route | Residues from solvents, unreacted starting materials | General chemical synthesis intermediates |
| Pharma/High Purity | Higher assay, trace-level organics specified | Water, residual acids, process-derived amines | APIs, controlled downstream reactions |
Impurity profiling addresses route-specific contaminants. The most frequent impurities originate from incomplete reaction, by-product formation during cyclopropane ring closure, and solvent/mineral acid carryover. Limits are tiered by grade: high purity calls for more stringent control, aligned with customer and pharmacopeial demands where relevant. Final acceptance criteria are determined by both in-process data and batch-to-batch trending.
Assay by HPLC or GC with route-validated reference standards forms the backbone of release testing. Water content is controlled by Karl Fischer titration. Identity and purity establishment rely on IR, NMR, and mass spectrometry for high-grade applications. For technical grades, basic melting point ranges and TLC comparisons may be accepted, though these do not satisfy regulated-use scenarios.
Cyclopropanecarboxamide production depends on reliable sourcing of cyclopropanecarboxylic acid, ammonia or amine reagents, and condensation catalysts. Regional material sourcing impacts impurity profiles, especially in relation to bio-based or petrochemical-derived cyclopropane intermediates. Vendor qualification ensures raw material traceability and supports impurity mapping efforts.
The common industrial route moves from cyclopropanecarboxylic acid (or its chloride) to the amide via amidation. Acid chloride routes involve phosgene substitutes or direct activation; milder paths deploy dicyclohexylcarbodiimide or similar coupling agents. Reaction mixtures require temperature control to restrain ring opening and prevent unwanted side reactions. Ammonolysis processes necessitate careful addition rates and containment due to the exothermic nature of amide bond formation.
Key control points include mixing speed, reagent addition rate, and endpoint temperature. Analytical in-process controls monitor conversion and by-product load. Work-up strategies focus on achieving effective phase separation and washing protocols. Purification may include crystallization, filtration, and activated carbon treatments to strip color and off-flavors, all selected according to the grade required. High purity requires controlled drying and inert storage, often under vacuum or nitrogen blanket.
Batch consistency draws on statistical process control and trending of key analytical attributes. QC release hinges on matching assay, impurity profile, and physical appearance against internal specifications and customer agreements. Any deviation is back-traced to either starting material variance or process parameter excursion.
Cyclopropanecarboxamide undergoes hydrolysis under acidic or basic conditions, yielding cyclopropanecarboxylic acid or corresponding amines. It can serve as a precursor for N-alkylation or further cyclopropane ring transformations. These pathways attract interest for agrochemical and pharma intermediates.
Reactions typically use organic solvents for solubility and heat management. Catalysts include mineral acids or organometallic bases, with process windows fine-tuned to grade-specific yield and selectivity requirements. Elevated temperature or extended reaction time increases risk of ring opening and impurity formation, demanding careful parameter selection.
The compound acts as a feedstock for synthesis of chain-extended amides, amines by reduction, and cyclopropyl-based specialty intermediates. Route and conditions impact overall downstream compatibility. End-product demands may dictate further purification or modification.
Material is stored in sealed, moisture-tight containers. Temperature control is set to prevent caking or hydrolysis, with well-ventilated, low-humidity storage preferred. Light avoidance is considered for high-purity products, preventing slight yellowing or decomposition. Use of inert gas back-fill is implemented for long-term storage of sensitive, high-grade stocks.
High-density polyethylene, glass, or lined-steel drums match chemical compatibility requirements. Unlined metals are typically not selected due to potential catalysis of degradation.
Shelf life is tracked by periodic re-test, as purity drifts non-linearly with environmental exposure. Signs of degradation include increased moisture content, visible yellowing, or shifting melting point. Storage conditions exert greater influence than time alone, with strict adherence to set points delivering maximum material stability.
Hazard classification reflects available toxicological data and exposure potential. The classification changes according to formulation, handling protocol, and regional regulatory updates. Official documentation always guides label and risk assessment protocol preparation.
Risk language derives from dust inhalation, skin/eye exposure potential, and risk of environmental release. Production areas apply engineering controls like dust collection, local exhaust, and personal protective equipment aligned with regulatory guidance and internal risk assessments.
Acute and chronic toxicity parameters are grade- and exposure-route-dependent, established with reference to latest clinical and workplace experience. Limits can be updated as new studies emerge or as customer application risk shifts.
Internal standard operating procedures define handling and allowable exposure based on observed process values and regional occupational health standards. Routine air and surface monitoring supplement risk management in large-scale production facilities, and spill control procedures are trained at all operational sites.
Cyclopropanecarboxamide production relies on established small- to mid-scale batch synthesis using cyclopropanecarboxylic acid derivatives. Output per campaign varies according to purification requirements, grade, and plant scheduling. Bulk pharmaceutical/intermediate grades require longer campaigns with higher throughput, while specialty and custom grades restrict batch size based on isolation and contamination risk control.
Seasonal raw material availability or upstream campaign changeovers may create short bottlenecks, especially where purified cyclopropanecarboxylic acid must be sourced outside the region.
Standard lead time falls between 2 and 6 weeks for repeat customers, heavily influenced by requested grade and order size. Non-standard purities and packaging needs increase production planning complexity. Minimum order quantities reflect reactor batch volume. For common grades, typical MOQs support kilo-to-multiton shipments, but high-purity or custom-formulated orders require negotiation depending on campaign allocation and packing configuration.
Packaging configures according to product grade and intended downstream handling. Bulk orders employ HDPE or stainless drums, with small packs—such as glass or fluoropolymer-lined bottles—used for lab-scale or high-purity requirements. Moisture and light protection standards follow grade-specific criteria, especially for reference or analysis-grade material where microbial ingress or trace contamination affect final assay or performance.
Export shipments observe hazardous goods classification where volatility and packaging integrity risk assessment demand. INCOTERMS align with standard conditions for chemical intermediates, and payment terms depend on volume, order frequency, and market region. Payment in USD or EUR dominates intercontinental transactions, with L/C or net payment terms for key repeat buyers.
Raw material cost primarily tracks cyclopropanecarboxylic acid, ammonia or amide-forming agents, and solvents. Fluctuations root in precursor supply (cyclopropane, ethylene intermediates), energy tariffs, and purification reagents. Commodity price indices for basic chemicals affect those input costs directly; specialty grades require additional purification or analytical release, increasing labor and consumable input share.
Observed pricing shifts often begin with producer nations’ supply chain interruptions, unplanned plant shutdowns, or regulatory interventions (environmental or labor compliance). Fluctuation also arises from currency shifts, logistics bottlenecks, and transport tariffs—particularly when shipping routes change due to geopolitical or safety events.
Grade and purity dictate base price. R&D and pharmaceutical buyers pay premiums for certified grades with batch homogeneity and validated impurity control, especially where regulatory submission or clinical use is targeted. Industrial grades command lower margins, primarily when minimum purity or functional performance meets downstream derivative synthesis. Packaging with certification (retraceability, inert linings, tamper-evidence) also increases unit cost, reflecting compliance-based labor, inspection, and third-party validation overhead.
Cyclopropanecarboxamide demand correlates with agrochemical, pharmaceutical precursor, and specialized polymer intermediate market needs. New drug projects and patent expiries in target regions push incremental demand. Global production base remains concentrated in East Asia, with auxiliary volumes in the EU and North America for full supply chain traceability and expedited delivery.
In the US/EU, market tightness follows regulatory-driven site restarts and disruptions. Buyers require documentation and traceability. Japan’s purchasing trends emphasize high-analytical standards, small-lot volumes, and tight producer qualifications. India focuses on price efficiency for generics and off-patent APIs, affecting tolerances for lower grade or slower lead times. Mainland China’s leading production role offers scale but remains exposed to logistical bottlenecks, energy prices, and environmental campaign shutdowns.
Industry data and procurement forecasts signal continued upward pricing pressure into 2026. Regulatory tightening in East Asia, rising solvent and purification material costs, and periodic plant capacities retiring amplify volatility. Contract buyers with locked-in supply windows face smaller escalators, but spot-market buyers encounter sharper increases, especially for high-specification and compliance-bound material grades.
Price, availability, and trend conclusions derive from internal campaign data, market monitoring by chemical purchasing consortia, and published average transfer prices from international trade agencies. Batch-specific historical variance also provides input where large volume buyers negotiate multiyear contracts.
Key events in the past two years include capacity expansion projects delayed by regional environmental reviews and licensing reviews resulting from new chemical registration regulations. At least one global supplier temporarily halted production for process revamp and safety system upgrades following updated occupational exposure standards.
Compliance with latest EU REACH and US TSCA protocols drives investment in analytical method development, traceability, and upstream impurity monitoring. Regular updates to global GHS hazard classification, packaging, and transport labeling standards require ongoing inventory retesting and relabeling on a batch basis.
Manufacturers adapt to compliance changes by increasing campaign traceability, thickening in-line analytical inspection points, and holding buffer stocks in bonded warehouses. Investment in process efficiency and closed-loop recycling for solvents helps limit cost inflation at the purification stage, particularly for high-purity grades. Cooperation with overseas logistics networks aims to smooth the impact of unpredictable shipping disruptions.
Cyclopropanecarboxamide finds industrial use in pharmaceutical intermediate synthesis, agrochemical research, and specialty chemical transformations. In pharmaceutical manufacturing, the compound acts as a building block for small-molecule active ingredients. Plant protection and crop science research use cyclopropanecarboxamide grades tailored for experimental formulation and scale-up studies. Specialty chemical producers may require customized impurity profiles or process adaptability based on application-driven synthesis needs.
| Application | Recommended Grade(s) | Key Characteristics |
|---|---|---|
| Pharmaceutical Intermediates | High-purity, API-intermediate grade | Controlled organic impurities, compliance with GMP principles on request |
| Agrochemical Synthesis | Technical, standard synthesis grade | Process-dependent purity; pesticides-specific residual control as required |
| Research & Pilot Projects | Research or pilot-batch grade | Batch-specific documentation, adaptable lot sizes, full impurity disclosure |
The suitability of cyclopropanecarboxamide depends on trace impurity levels, moisture content, solvent residue, and lot-to-lot reproducibility. Pharmaceutical applications often require the most stringent organic and inorganic impurity controls, trace metal analysis, and full batch documentation. Agrochemical processes may prioritize process compatibility, cost-per-batch, and defined minimum purity. Research institutes typically ask for small pack sizes, batch tracking, and detailed certificates of analysis.
Production departments must match grade output to customer end-use. Pharmaceutical manufacturers usually communicate targeted impurity thresholds, residual solvents, and trace metals based on finished product purity. Agrochemical users frequently focus on cost-effective bulk supply, with some flexibility on impurity controls aligned to downstream process tolerance.
Quality control staff should review whether the application falls under APIs, food-bound derivatives, or regulated pesticide intermediates. International markets will expect country-specific compliance. If the output enters regulated drug paths, discussion with regulatory teams is mandatory to map out full documentary support, traceability controls, and qualifying process routes.
Not all processes require highest purity. Production often chooses purification intensity and final release standards by considering the chemical sensitivity of downstream steps. Technical-grade output may suffice if the next process purifies the intermediate further, but high-end pharmaceutical users rely on advanced column chromatography, in-depth QC regimes, and defined residual cut-offs.
Batch consistency becomes more complex as order volumes increase. For ongoing production, process optimization favors stable supply sources and fixed grading protocols. Research and pilot-scale demand rarely justifies specialty purification unless project progress supports technical upgrade. Volume pricing discussions link back to raw material type, process yield, purification loss, and batch rejection risk.
Sample validation is standard practice before commercial supply. Both quality and technical support teams review in-house analytics and compare to customer method requirements. Feedback on solubility, particle characteristics, compatibility, and impurity fingerprinting helps adjust the process. Sample assessment closes the application–grade matching cycle and reduces downstream risk in full-scale production.
From a manufacturer’s operations standpoint, the backbone of reliability in Cyclopropanecarboxamide production involves maintaining internationally accepted quality management systems. Facilities are routinely audited and certified to recognized standards, such as ISO 9001. Certification scope covers upstream procurement, raw material traceability, batch processing control, and downstream logistics. Certification renewals hinge on transparent records, organized deviation handling, and corrective action protocols that reflect the realities of day-to-day plant operation, not just paperwork exercises. For buyers, these systems ensure that batch discrepancies, out-of-spec events, and process upsets are documented, not hidden, and remediated according to a defined escalation path.
Certification beyond general ISO frameworks often arises due to end-use application needs. Pharmaceutical or agrochemical-grade Cyclopropanecarboxamide demands more frequent analysis of critical impurities and may require third-party audits from regulatory or customer-appointed teams. Documentation might include DMFs, GMP audit reports, or food/animal feed compatibility assurances. Where product grades differ (industrial, technical, or high-purity), so do the applicable certifications and frequency of external and internal review.
Routine manufacturing practice includes maintaining batch records, certificates of analysis, and impurity profiles for each production lot. Documentation defines manufacturing route, raw material lot numbers, in-process testing, and out-of-trend event logs. Where application or region-specific documentation is needed — such as REACH dossiers, transport classification statements, or customer audit reports — supply can be customized. Manufacturer technical teams interpret analytical results in direct context of batch history, rather than as stand-alone values, which is critical for trace-back and continuous improvement. Inquiries regarding trace levels or additional data are managed by direct dialogue between QA, technical, and procurement teams.
Cyclopropanecarboxamide output is governed by committed manufacturing slots, raw material security of supply, and process cycle timing. Forward planning with customers enables scheduling of standard runs or campaign manufacture for larger-volume or custom-specification orders. For unpredictable demand, flexible supply agreements consider minimum-recall and rapid-release batches, provided core production processes remain uninterrupted. Coordination with buyers includes regular yield reporting, short-term forecast adjustments, and emergency supply provisions during logistics or regulatory interruptions.
Capacity allocations derive from installed reactor volume, validated cleaning cycles, and scheduled preventive maintenance. Core lines are reserved for critical or recurring volume customers, reducing the risk of cross-contamination or production delays caused by grade changeovers. Manufacturers monitor market fluctuations in precursor materials and energy costs to buffer against unexpected shortages or cost spikes, which supports stable downstream supply. Raw material vendor performance gets reviewed on a routine basis to sustain supply chain resilience.
Sample requests often originate from R&D or QC functions at the customer end, aiming to match specific formulation or process trials. Each sample dispatch includes traceable batch documentation and reflects current production status (e.g., campaign, validation, or routine). Quality group reviews the sample’s intended use — whether analytical reference, process trial, or regulatory submission — and supports dialogue with customer technical teams on analytical methods or application nuances.
Business models address both stable long-term demand and occasional spot purchasing. Long-term partners typically opt for rolling forecasts, fixed quantity windows, or volume rebates for commitment. For customers with variable schedules or evolving project needs, short lead-time call-off orders or consignment arrangements can be structured without hard constraints on annual volume take-off. Multisite manufacturing or toll production backup can be initiated during planned shutdowns or emergency events when uninterrupted supply is critical for the buyer’s processes. Contractual flexibility includes technical support visits, rapid troubleshooting communication channels, and batch reservation protocols which fit specialized customer workflows.
Process optimization for cyclopropanecarboxamide mainly focuses on streamlining cyclopropanecarbonylation and amide formation under controlled conditions. Labs concentrate on maximizing chemical throughput by improving reaction temperature profiles, monitoring batch-to-batch reproducibility, and reducing side-product formation such as ring-opened amides or N-substituted derivatives. Selection and purification of starting cyclopropanecarboxylic acid or acid chloride remain widely studied due to variability in feedstock purity across regions. Analytical method development for low-level impurity detection—especially for isomeric species—draws continuous internal attention. Routine HPLC or GC-MS fingerprinting forms the backbone of industrial R&D work on this molecule.
Interest has risen in the use of cyclopropanecarboxamide as a synthetic intermediate or building block in the agrochemical sector and pharmaceutical synthesis pipelines. Process chemists evaluate its role in active compound library expansion, fragment-based drug design, and as a masked amine donor. Downstream application often dictates the amide grade required for custom syntheses or scaled multi-step campaigns. Some customers require differentiated handling based on potential for functionalization at the cyclopropyl motif or amidic nitrogen, tailoring batch acceptance criteria to downstream transformation targets.
Process engineers contend with ring-opening byproducts during large-scale synthesis, especially in continuous flow systems or under variable moisture content. Scale-up beyond bench batch sizes introduces inter-batch variance due to thermal and mass-transfer gradients, calling for stringent temperature and pH control. Innovations in in-line process analytical technology (PAT) enable real-time monitoring of conversion and purity profiles. Breakthroughs include adoption of milder coupling reagents minimizing the formation of colored or volatile impurities, and incremental improvements in mother liquor recycling and trace-metal removal. Each modification responds to both regulatory expectations and customer feedback on impurity spectra.
Global demand for cyclopropanecarboxamide is set to track new active ingredient synthesis in pharmaceuticals and crop science, especially where cyclopropyl motifs offer regulatory or efficacy advantages. As stricter quality standards emerge in key manufacturing regions—reflecting both environmental codes and downstream customer presentations—producers anticipate more granular segmentation of batch grades by impurity threshold and trace residue profiles. Larger-volume customers begin to request supply chain transparency, prompting closer tie-in between raw material audits and QA documentation.
Continuous-flow reactors gain uptake for streamlining amide formation, enabling real-time impurity tracking and safer scaling. Sophisticated analytical techniques—UPLC, HRMS—move from QC labs to in-process monitoring, targeting endpoint criteria not just for bulk purity, but also for trace-level extractables and leachables. Key drivers for process change involve reductions in solvent waste, energy consumption in reflux or distillation steps, and enhancement of batch-to-batch consistency through automated dosing systems. Technology transfer teams document these protocol improvements in batch production records and technical notes for customer audit review.
Minimizing environmental load forms the basis of ongoing investment, with attention to solvent selection, effluent treatment, and chemical step count. Green chemistry protocols push selection toward benign reagents and lower-toxicity coupling agents. Manufacturing process route selection considers regional wastewater discharge limits and solvent recovery infrastructure; thus, greener synthesis is sometimes grade- or plant-specific depending on local compliance requirements. Producer teams work to phase out halogenated solvents, increase closed-loop purification, and develop recyclable catalyst systems, guided by both market and internal sustainability targets.
Customers often seek support in integrating cyclopropanecarboxamide into new multi-step syntheses or for process troubleshooting tied to purity shifts between supply batches. The R&D and technical service teams provide data on route-specific impurity generation, recommend grades for different downstream strategies, and interpret certificate of analysis (CoA) data points tied to their applications. For process validation, teams share detailed analytical data and respond rapidly to customer-initiated deviation reports to address both routine and atypical questions.
For process scale-up and formulation adaptation, support teams help resolve operational questions related to solubilization, batch handling under dry and inert conditions, and the impact of residual water or non-target isomers on subsequent reactivity. Formulatory teams relay experience gained across application sectors—pharmaceutical, agrochemical, material science—while remaining sensitive to proprietary concerns. Case-specific advice extends to recommendations on storage stability protocols, blending procedures, and impurity mitigation tactics, aligning with both release standards and unique customer requirements.
After-sales responsibility extends beyond documentation delivery; QA teams respond to feedback on material consistency or unexpected analytical results within defined timeframes. Ongoing review of customer input (process deviations, analytical anomalies, shipment conditions) shapes future production runs and technical bulletins. Release criteria reflect both internal benchmarks and targets determined in concert with the most critical application sectors. Material traceability, rapid root-cause investigation, and willingness to provide supplementary technical documentation reinforce long-term supply relationships and enable timely adaptation to evolving downstream standards.
We manufacture Cyclopropanecarboxamide at our integrated facility, beginning with raw material selection and following a tightly controlled synthesis route. Our production team manages every reactor and downstream process in-house, overseeing purity and impurity profiles at each critical stage. This approach eliminates external uncertainties, delivers full traceability, and assures batch reproducibility across supply cycles.
Our Cyclopropanecarboxamide supports a range of industries that require stable intermediates and process reliability. Pharmaceutical customers employ this amide for building complex molecular scaffolds, often as a key step in active pharmaceutical ingredient synthesis. Agrochemical manufacturers integrate it in the creation of specialized crop protection agents. In materials science, it contributes to advanced polymer projects requiring strained ring systems. We customize output volumes for multi-ton commercial runs and smaller projects, based on clients’ production schedules or scale-up needs.
In-process monitoring forms the backbone of our quality management. We operate in-line GC and HPLC systems to scrutinize product purity and byproduct levels in real time. Every batch undergoes verification against internal specifications set above common market standards. Our QC staff conducts lot sampling, purity checks, and full documentation before packaging begins. This hands-on oversight avoids inconsistencies that result from variable sourcing or loosely controlled batch manufacturing.
We deliver Cyclopropanecarboxamide in packaging formats selected for chemical integrity, safety, and handling efficiency. Options include HDPE drums, stainless steel containers, and lined IBCs, depending on client operational flow and warehouse systems. Every load receives secure labeling, tamper-evident closures, and logistics scheduling according to delivery frameworks agreed with industrial customers. Our dedicated shipment coordinators monitor route progress and can fulfill Just-In-Time deliveries as production pipelines require.
Complex projects demand robust technical support. We maintain a process support team with direct experience in product use, impurity impact, and downstream conversion. Troubleshooting and process optimization discussions begin at the technical level—our chemists and engineers work directly with plant or R&D teams. All feedback informs our production adjustments, whether it means refining synthesis for a customer-specific impurity spec or recommending optimal storage arrangements for extended projects.
Direct supply from a manufacturer reduces risk, streamlines lead times, and avoids the pricing volatility seen with indirect channels. We make our production schedule transparent to industrial buyers, allowing for clear demand planning and cost management over the contract period. Our logistics and technical infrastructure support distributors looking to stabilize downstream offerings and improve supply reliability for their own clients. Procurement teams gain contract certainty, batch-level documentation, and continuity from a single producer accountable for every aspect of the supply chain.
Cyclopropanecarboxamide holds a notable spot in our production line because of a combination of its ring strain, stability, and amide functionality. The three-membered cyclopropane core is rigid and stores significant strain energy. This gives it patterns of chemical reactivity that stand apart from larger-ring amides or straight-chain analogues. Researchers often leverage this ring strain for synthetic transformations that ask for controlled reactions or need an energetic scaffold. Industrial chemists have shown growing interest in this compound for its involvement in the design and discovery of novel molecules, especially in the pharmaceutical field, due to its distinct backbone.
The physical properties shape both our large-scale handling and our customers’ lab practices. Cyclopropanecarboxamide typically presents as a solid at ambient temperatures, and its melting point bracket enables easy weighing and transfer without unnecessary volatility loss or dusting in open reactors. Our plant operates with closed systems to contain both powder and vapors, ensuring process safety and batch consistency. Moisture uptake remains low due to its amide nature, though, as with many low-molecular-weight amides, we advise customers to store the product in a dry environment to block hydrolysis or caking, preserving sample integrity over longer campaigns.
Solubility factors into both synthetic utility and downstream processing. Cyclopropanecarboxamide shows moderate polar solvent solubility—readily dissolving in common alcohols and partially miscible with water. This aligns with the compound’s moderate polarity, which stems from the amide group and the cyclopropane backbone. End-users in organic synthesis often favor these solubility dynamics for reactions in protic or aprotic polar media. Our downstream isolation protocols capitalize on this solubility range, supporting efficient purification and minimizing waste streams.
Thermal behavior guides much of our scale-up and transport strategy. This compound resists moderate heat, without signs of decomposition under standard laboratory synthetic temperatures. Our technical team sets a routine monitoring threshold for thermal degradation to manage long-haul shipments and extended storage. Maintaining a facility environment that shields against both excessive heat and moisture forms a foundation of our bulk warehousing.
One common question from research and pilot plant clients concerns chemical compatibility. The cyclopropane ring can induce localized strain-sensitive reactivity, especially under strongly acidic or basic conditions, and during hydrogenation. Our technical specialists remind clients that the amide carbonyl is less reactive than esters or anhydrides, which broadens the operational window for selective transformations. These features enable chemists to fine-tune their synthetic sequences while keeping unwanted side reactions low.
Impurity control represents an ongoing focus in our operations. Process-by-process, we optimize cyclopropanecarboxamide production to limit side-product formation from ring opening or N-alkylation. Downstream, our QA team runs systematic chromatographic checks, and we keep a technical file with spectra and analytical methods on hand for our frequent buyers. Fast and transparent technical support helps our industry partners manage specifications with certainty and keeps R&D projects on schedule.
Drawing on these physical and chemical traits, we work directly with experienced chemists and formulation teams to troubleshoot application challenges. We have the ability to adjust batch sizes, advice on scale transfer, and supply documentation for regulatory needs, giving our partners full confidence in the material they receive. Our process design and quality commitment remain the backbone for any industrial or academic project involving cyclopropanecarboxamide.
Every day our processes run with a single goal: ensure quality chemical production with clear, reliable supply chain answers. Bulk procurement brings its own set of expectations—secure delivery, consistent supply, and packaging that suits commercial production lines. With cyclopropanecarboxamide, the packaging must support both handling efficiency and product safety.
For large orders, our standard bulk packaging consists of 25 kg fiber drums with inner polyethylene liners to protect the cargo against moisture and contamination. This format maximizes logistical efficiency and helps our clients receive manageable loads without compromising integrity. For plants requiring higher-capacity, we offer 200 kg high-density polyethylene drums on reinforced pallets. These industrial drum units support mechanized unloading and have a solid track record during international transit.
We've found that requests for intermediate sizes, such as 50 kg or 100 kg drums, do occur. Our flexibility as a direct manufacturer lets us accommodate these orders without disrupting upstream production. Larger format packaging—such as 500 kg or 1000 kg intermediate bulk containers—can be arranged for specialized handling systems, provided the client's storage and transfer facilities can handle these units safely.
Production scheduling for bulk delivery draws on real-time inventory, current contract volume, and shipping requirements. For most standard bulk orders, we target a lead time of 2 to 3 weeks from order confirmation to shipment release. This timeframe covers pre-shipment batch analysis, drum/container filling, and completion of all required documentation.
Orders that match our regular production campaign for cyclopropanecarboxamide usually ship at the shorter end of this estimate. If clients request non-standard packaging or if orders fall outside the cycle, coordination with our operations team may add extra days for drum procurement or re-tooling filling lines.
Some clients require phased deliveries as part of long-term supply contracts. Our logistics division can break down the main order into regular shipment lots, providing reliability over the contract term to match clients’ manufacturing plans.
Our technical support team works directly with customers to optimize packaging decisions before production ramps up. Accurate order forecasting from our commercial partners allows us to reserve drum inventory and streamline plant scheduling. Early notification about order changes, preferred ship dates, or special packaging pays dividends for everyone. Fewer gaps for our customers, less idle inventory risk for us.
For highly sensitive customer requirements—such as custom labeling, special seals, or declared bagging specs for export—every detail must be set before production starts. We urge clients to outline these parameters at the earliest stage so the finished drums or containers match technical and regulatory demands when leaving our facility.
Factory-direct supply means transparency and fast response. Every barrel, drum, or container filled at our plant is backed by the same commitment to safety, purity, and dispatch reliability. Bulk chemical buyers looking for cyclopropanecarboxamide get options built on decades of in-house experience, not speculation. From packaging flexibility to scheduling transparency, our team stands behind every shipment, from filled drum to sealed container.
Shipping Cyclopropanecarboxamide to overseas customers brings a full set of responsibilities for us as a manufacturer. Each stage in the journey—from factory floor, through customs checkpoints, into warehouses, and out to site labs—depends on careful interpretation of chemical regulations, solid logistics, and robust quality assurance. We’ve moved thousands of kilograms of Cyclopropanecarboxamide across global markets. In our experience, generalizations do not match the real-world demands that regulators and end-users set for this compound.
We package Cyclopropanecarboxamide in tightly sealed HDPE drums and, for smaller amounts, high-integrity aluminum cans. Sensitivity to moisture and potential cross-contamination means we run batch-specific closed-loop filling. With every lot, we use tamper-evident seals and batch tracking. In our own warehouse, drum stacking protocols and physical barriers prevent accidental puncture or spillage.
Our international partners often require shipper’s declarations and Material Safety Data Sheets (MSDS) compliant with their local versions of GHS labeling. From the outset, marking and documentation match the UN/IMDG (sea freight) or IATA (air) requirements, noting any hazard classification, even though Cyclopropanecarboxamide is not listed as a major hazardous chemical in most registrations. Customs authorities still expect accurate chemical identifiers, hazard pictograms, and emergency phone numbers posted on all transport documents. Failure to comply with this paperwork can lead to shipment delays, extra inspections, or outright rejection at the destination port.
We recommend storing Cyclopropanecarboxamide between 2–8°C in a dedicated dry warehouse zone, away from oxidizers and acids. In our own facilities, insulation safeguards temperature, and digital logging tracks fluctuations. Uncontrolled temperature swings shorten shelf life and raise impurity risks, so even on short-term warehousing at a distribution hub, we train staff in both temperature monitoring and secondary containment response.
If a product remains out of our custody too long, we see increased discoloration or the appearance of hydrolysis byproducts. For this reason, we minimize total time in transit and coordinate with logistics partners to avoid weekend or customs-holding delays. Warehouses handling general chemicals without staff trained for fine organics may pose longer-term risks to consistency and traceability.
Each country sets its own entry requirements for Cyclopropanecarboxamide. Our compliance team reviews not just the standard REACH, TSCA, or Chinese MEE obligations, but also downstream uses declared by the importer. For instance, shipments to the EU require a full REACH registration dossier, supported by our own analytical data, stability studies, and impurity profiles. We maintain all records internally, ready to submit in case of post-entry inspection or audit from authorities.
In certain cases, Cyclopropanecarboxamide falls within local "chemical of interest" lists. Australian or South American importers often face unique product notification or pre-shipment labelling standards. We address this directly with the relevant documentation, pro-actively updating our paperwork as regulations change. Unexpected audits or spot checks prompt us to keep both original batch certificates and full traceability records on file at all times.
As producers, transportation compliance is not just about ticking boxes. Downtime at a port or rejected drums eat into our delivery performance and compromise partnerships. We align warehousing, shipping, and customs preparation well before the order leaves our door. Collaborating with local consignees and customs brokers ensures that nothing gets lost in translation between regulatory agencies. We continue to invest in compliance software and staff training. Our technical and logistics teams remain available to advise importers who encounter evolving regulations or face on-site audits post-arrival.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
